COUR Pharmaceuticals

• locale

  United States

• market

  PRIVATE

• industry

  Biotechnology

• website

  courpharma.com

COUR Pharmaceuticals is developing therapies designed to reprogram the immune system to achieve antigen-specific tolerance for immune-mediated disease. This includes a platform of immune-modifying nanoparticles aimed at treating the root cause of immune disease.